Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2023

The global COVID-19 pandemic had a slight negative impact on the Latin America IC market in the short term. The market will grow moderately through 2031, with the expanding CAD procedure volume and increasing adoption of advanced devices, especially in the coronary stent segment. However, the market is limited by the lack of reimbursement and continuing budgetary constraints among Latin American facilities leading to inhibit the uptake of high-cost products.

This Medtech 360 Report provides high-level market metrics for interventional cardiology devices in the Latin American region, including country-level data for major countries and aggregate data for the rest of the Latin America from 2019 through 2031.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectable market is expected to experience rapid growth through 2034. This expansion will be driven by product development and differentiation efforts from market…
Report
Biosurgical Agents – Market Insights – Latin America (Supplemental)
The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable…